Co-Authors
This is a "connection" page, showing publications co-authored by Guillaume Martin-Blondel and Pierre Delobel.
Connection Strength
0.458
-
Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clin Infect Dis. 2020 12 31; 71(11):2962-2964.
Score: 0.230
-
Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. BMC Pharmacol Toxicol. 2021 03 11; 22(1):14.
Score: 0.058
-
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study. Fundam Clin Pharmacol. 2021 Feb; 35(1):194-203.
Score: 0.057
-
Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort. Rev Med Interne. 2020 Nov; 41(11):732-740.
Score: 0.057
-
COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network. J Neurol Neurosurg Psychiatry. 2020 09; 91(9):1004-1006.
Score: 0.056